Across TCGA pan-cancer cohorts, CDY13P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated CDY13P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CDY13P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY13P expression acts as an unfavorable survival marker.

HNSC are the cancer types where CDY13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.181	0.687	.006	108	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CDY13P tumor-vs-normal RNA expression · all CDY13P data types